Advocacy intelligence hub — real-time data for patient organizations
Biobizkaia Health Research Institute — PHASE4
Hywel Dda Health Board
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Kai Zhang, MD
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Francis WB Sanders, MB BChir PhD FRCOphth
Hywel Dda University Health Board
Karim Hammamji, MD
Centre hospitalier de l'Université de Montréal (CHUM)
Laura Andres-Martin, PhD
New York Stem Cell Foundation Research Institute
Ronald Klein, MD, MPH
University of Wisconsin, Madison
Alberto L Gil, MD
Federal University of Health Science of Porto Alegre